Effect of Medicare dialysis payment reform on use of erythropoiesis stimulating agents

Health Services Research

Volumn 50, Issue 3, 2015, Pages 790-808

  Swaminathan, Shailender ^a,b   Mor, Vincent ^a,b   Mehrotra, Rajnish ^a,b   Trivedi, Amal N ^c  

^a BROWN UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

bundled payments; incentive; Medicare; Renal dialysis

Indexed keywords

ALBUMIN; ANTIANEMIC AGENT; HEMOGLOBIN;

ADULT; ARTICLE; BODY MASS; END STAGE RENAL DISEASE; FEMALE; HEALTH CARE POLICY; HEMATOCRIT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; MEDICAL INFORMATION SYSTEM; MEDICARE; MIDDLE AGED; REIMBURSEMENT; RENAL REPLACEMENT THERAPY; AGED; ECONOMICS; GOVERNMENT; KIDNEY FAILURE, CHRONIC; ORGANIZATION AND MANAGEMENT; PROCEDURES; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); FEMALE; HEMATINICS; HEMATOCRIT; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; REIMBURSEMENT MECHANISMS; REIMBURSEMENT, INCENTIVE; RENAL DIALYSIS; UNITED STATES;

EID: 84929672476     PISSN: 00179124     EISSN: 14756773     Source Type: Journal    
DOI: 10.1111/1475-6773.12252     Document Type: Article

References (25)

1. Besarab, A., W. K. Bolton, J. K. Browne, Egrie, J. C., Nissenson, A. R., Okamoto, D. M., Schwab, S. J., and, Goodkin, D. A., 1998. " The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and Epoetin." New England Journal of Medicine 339: 584-90.
2. Brookhart, A. M., S. Schneeweiss, J. Avorn, B. D. Bradbury, J. Liu, and, W. C. Winkelmayer,. 2010. " Comparative Mortality Risk of Anemia Management Practices in Incident Hemodialysis Patients." Journal of the American Medical Association 303 (9): 857-64.
3. CMS. 2004. " Centers for Medicare and Medicaid Services: CMS Bundled Payment for Care Initiative. September 2012 " [accessed on September 15, 2012]. Available at http://www.innovations.cms.gov/initiatives/bundled-payments/index.html
4. CMS. 2011. " Centers for Medicare and Medicaid Services: Fact Sheet. November 2011 " [accessed on September 22, 2012]. Available at http://www.cms.gov/apps/media/press/factsheet.asp?counter=4148
5. CMS.gov. 2012. Renal Management Information System (REMIS) [Internet]. Baltimore, MD: Centers for Medicare and Medicaid Services [accessed on July 25, 2012]. Available at http://www.cms.gov/Research-Statistics-Data-and-Systems/Files-for-Order/IdentifiableDataFiles/RenalManagementInformationSystem.html
6. Drüeke, T. B., F. Locatelli, N. Clyne, K. U. Eckardt, I. C. Macdougall, D. Tsakiris, H. U. Burger, and, A. Scherhag, for the CREATE Investigators. 2006. " Normalization of Hemoglobin Levels in Patients with Chronic Kidney Disease and Anemia." New England Journal of Medicine 355 (20): 2071-84.
7. Federal Register. 2010. " Medicare Program; End-Stage Renal Disease Prospective Payment System; Final Rule and Proposed Rule." Federal Register 75 (155): 49030.
8. Federal Register. 2012. " Medicare Program; End-Stage Renal Disease Quality Incentive Program. Final Rule." Federal Register 76 (3): 628.
9. Food and Drug Administration [FDA]. 2007. [accessed on September 12, 2012]. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm109024.htm
10. Food and Drug Administration [FDA]. 2011. [accessed on September 20, 2012]. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm260670.htm
11. Iglehart, J. K., 2011. " Bundled Payment for ESRD-Including ESAs in Medicare's Dialysis Package." New England Journal of Medicine 364 (7): 593-5.
12. Mechanic, R. E., 2011. " Opportunities and Challenges for Episode-Based Payment." New England Journal of Medicine 365 (9): 777-9.
13. MedPAC. 2011. Report to the Congress: Medicare Payment Policy [Internet]. Washington, DC: Medicare Payment Advisory Commission [MedPAC]. [accessed on July 24, 2012]. Available at http://medpac.gov/documents/Mar11-EntireReport.pdf
14. National Kidney Foundation [NKF]. 2007. " KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target." American Journal of Kidney Diseases 50 (3): 471-530.
15. Nissenson, A. R., T. J. Mayne, and, M. Krishnan,. 2011. " The 2011 ESRD Prospective Payment System: Perspectives from DaVita, a For-Profit Large Dialysis Organization." American Journal of Kidney Diseases 57 (4): 550-2.
16. Pfeffer, M. A., E. A. Burdmann, C. Y. Chen, M. E. Cooper, D. de Zeeuw, K. U. Eckardt, J. M. Feyzi, P. Ivanovich, R. Kewalramani, A. S. Levey, E. F. Lewis, J. B. McGill, J. J. V. McMurray, P. Parfrey, H. H. Parving, G. Remuzzi, A. K. Singh, S. D. Solomon, and, R. Toto, R., for TREAT Investigators. 2009. " A Trial of Darbepoetin Alpha in Type 2 Diabetes and Chronic Kidney Disease." New England Journal of Medicine 361 (21): 2019-32.
17. Robinson, B. M., D. S. Fuller, B. A. Bieber, M. N. Turenne, and, R. L. Pisoni,. 2012. " The DOPPS Practice Monitor for US Dialysis Care: Trends through April 2011." American Journal of Kidney Diseases 59 (2): 309-14.
18. Rubin, D., 1977. " Assignment to Treatment on the Basis of a Covariate." Journal of Educational and Behavioral Statistics 2: 11-26.
19. Singh, A. K., L. Szczech, K. L. Tang, H. Barnhart, S. Sapp, M. Wolfson, and, D. Reddan, for CHOIR Investigators. 2006. " Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease." New England Journal of Medicine 355: 2085-98.
20. StataCorp. 2011. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP.
21. Swaminathan, S., V. Mor, R. Mehrotra, and, A. Trivedi,. 2012. " Medicare's Payment Strategy for End-Stage Renal Disease Now Embraces Bundled Payment and Pay-for-Performance to Cut Costs." Health Affairs 31 (9): 2051-8.
22. Thamer, M., Y. Zhang, J. Kaufman, D. Cotter, F. Dong, and, M. A. Hernan,. 2007. " Dialysis Facility Ownership and Epoetin Dosing in Patients Receiving Hemodialysis." Journal of the American Medical Association 297 (15): 1667-74.
23. Thistlewaite, D. L., and, D. T. Campbell,. 1960. " Regression-Discontinuity Analysis: An Alternative to the Ex Post Facto Experiment." Journal of Educational Psychology 51: 309-17.
24. U.S. Renal Data System. 2009. USRDS 2009 Annual Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive Kidney Diseases.
25. Winkelmayor, W. C., and, G. M. Chertow,. 2011. " The 2011 ESRD Prospective Payment System: An Uncontrolled Experiment." American Journal of Kidney Diseases 57 (4): 542-6.